drugset / Trial / NCT02761005
Eradication of H. Pylori Therapy Individualized by the Mutation of 23S rRNA of H. Pylori
Non-randomizedParallel-groupOpen-labelTreatment
Summary
Patients infected with H. pylori are treated with the individualized regimen which is based on the mutation of 23S rRNA of H. pylori.
Timeline
- Start
- 2016-05
- Primary completion
- 2018-03
- Completion
- 2018-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Clarithromycin | Small molecule | 200 mg | — |
| Subject | Metronidazole | Small molecule | 250 mg | — |
| Background | Amoxicillin | Other / unclassified | 750 mg | — |
| Background | Vonoprazan | Other / unclassified | 20 mg | — |